CD62L- Tem

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
60	再生不良性貧血	1

60. 再生不良性貧血

臨床試験数 : 245 / 薬物数 : 318 - (DrugBank : 86) / 標的遺伝子数 : 44 - 標的パスウェイ数 : 166

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03836690 (ClinicalTrials.gov)	October 21, 2019	10/1/2019	Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation	Phase I Study of Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplant ...	Lymphoma;Leukemia;Myeloma;Myelodysplastic Syndromes;Severe Aplastic Anemia;Primary Immune Deficiency ...	Biological: CD62L- Tem	University College, London	Medical Research Council	Recruiting	16 Years	70 Years	All	18	Phase 1	United Kingdom

First Previous1Next Last